Skip to main content

Good Therapeutics

Seattle, United States

Good Therapeutics develops new technology for self-regulating drugs that will provide a therapeutic activity when, where it is needed.

$8.0M raised
Dec 2021
Series B

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Good Therapeutics

How much funding has Good Therapeutics raised?
Good Therapeutics has raised $8.0M in total funding. The most recent round was Series B. The last funding was announced in December 2021.
Who are Good Therapeutics's investors?
Good Therapeutics's investors include Digitalis Ventures, RiverVest, Codon Capital, 3×5 Partners, Roche Venture Fund.
Where is Good Therapeutics headquartered?
Good Therapeutics is headquartered in Seattle, United States.
What does Good Therapeutics do?
Good Therapeutics develops new technology for self-regulating drugs that will provide a therapeutic activity when, where it is needed.
What stage is Good Therapeutics at?
Good Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Good Therapeutics — Funding & Investors." VCBacked, December 30, 2021, https://www.vcbacked.co/company/good-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2021). Good Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/good-therapeutics
Wikipedia (cite web)
{{cite web |title=Good Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/good-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .